Aufklappen
Schliessen
- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten |
|---|---|
| 13:31 | Boehringer taps Korea's Bridge for Ofev follow-up |
| 13:31 | Pear Therapeutics submits latest digital therapeutic, insomnia and depression treatment |
| 12:31 | Novartis and J&J back latest €400m Medicxi biopharma fund |
| Do | Von der Leyen elected new European Commission president |
| Do | Novartis raises 2019 guidance as new products gather speed |
| Do | New digital director for 90TEN |
| Do | Elon Musk's NeuraLink applies to trial 'brain-machine interface' |
| Do | New UK leadership roles at WPP Health Practice |
| Mi | Illumina sets up first ex-US accelerator site in Cambridge |
| Mi | Kisqali combination follows Verzenio onto Cancer Drugs Fund |
| Mi | Genentech taps into Sosei Heptares GPCR expertise with $1bn alliance |
| Di | ACPs to lead gene therapies in haemophilia market growth |
| Di | FDA starts speedy review of Novartis' sickle cell antibody |
| Di | Recursion raises $121m for AI-led drug discovery |
| Di | AbbVie cures STING fever with Mavupharma acquisition |
| Mo | Gilead strikes $5.1bn deal to bolster ties with Galapagos |
| Mo | AbbVie's Skyrizi gets rapid 'yes' from NICE |
| Mo | Amgen gets block on sales of Repatha rival in Germany |
| 12.07. | Reckitt hammered by $1.4bn opioid settlement bill |
| 12.07. | Amgen and Novartis abandon Alzheimer's drug after worsening symptoms |
| 11.07. | Another setback on pricing as Trump drops rebate plans |
| 11.07. | FDA will maintain the pace, vows Woodcock, but warns of skills gap |
| 11.07. | ViiV builds case for switching to its two-drug HIV combinations |
| 11.07. | FDA verdict on Sanofi's Darzalex rival is due in April 2020 |
| 10.07. | Amazon's Alexa to provide NHS health information |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und mit der Push-Technologie von
Nachrichten • Aktienkurse • DAX • Xetra-Orderbuch • Watchlist
Ad hoc-Mitteilungen • Nachrichten Börsen • Aktien-Empfehlungen
Branchen • Medien • Nachrichten-Archiv
Impressum | AGB | Disclaimer | Datenschutz • Presse • Mediadaten
RSS-News von FinanzNachrichten.de kostenlos für Ihren Browser und Ihre Homepage
